COVID-19 / FLU A & B
RAPID TESTING

CALL TO ORDER
(800) 675-1202
WHAT IS IT?
Lateral flow immunochromatographic assay intended for the qualitative detection and differentiation of influenza A, and influenza B nucleoprotein antigens and SARS-CoV-2 nucleocapsid antigens.
Box of 25 test cassettes.
Lateral flow immunochromatographic assay intended for the qualitative detection and differentiation of influenza A, and influenza B nucleoprotein antigens and SARS-CoV-2 nucleocapsid antigen directly from anterior nasal swab specimens of individuals with signs and symptoms of respiratory infection consistent with COVID-19 by their healthcare provider within the first 5 days of symptom onset when tested at least twice over three days with at least 48 hours between tests. Clinical signs and symptoms of respiratory viral infection due to SARS-CoV-2 and influenza can be similar. Positive results do not rule out bacterial infection or co-infection with other viruses.
Detect Three Respiratory Viruses Simultaneously from a Single Sample:
Faster diagnosis for improved patient care and cost-effectiveness
-
Rapid Detection: Results available in 15 minutes
-
Excellent Test Performance (comparator method RT-PCR)
-
Simple and Effective: CLIA Waived testing at the point-of-care for use with minimally trained healthcare professionals
-
External Quality Controls Available: Facilitates routine quality procedures
-
Shelf Life that Spans Viral Seasonality: 16 months from date of manufacture at room temperature storage

Specifications |
|---|


